about
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines.Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines.Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells.Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration.Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells.Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines.Topoisomerase-II-mediated DNA cleavage within the human ribosomal genes.Inhibition of topoisomerase II activity and its effect on nucleolar structure and function.JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In VitroLocation of rRNA transcription to the nucleolar components: disappearance of the fibrillar centers in nucleoli of regenerating rat hepatocytes
P50
Q33810548-CBBD7C1A-4501-414E-B9B7-8A622CF90E97Q38843303-F6D2BA21-482A-40CE-B7C8-EE629F091145Q39135553-B29635A1-F08F-4493-BA1C-3CC0143CE4AAQ39396436-90A873CF-0D51-4360-8B18-A76ADDEBE223Q39457252-FB5ECFB3-B193-4BDC-BF1C-7E1B369744A5Q40106485-3974086F-10AB-4F5E-A902-28B3BC6779CFQ40174000-639F12E0-2C5A-4926-B9A4-23501E57705BQ40511635-0998F8A8-F110-4770-885F-942D8BF6AC23Q40750030-FE8E2F73-1A75-49A1-A5ED-44050E463AE6Q41313299-D61C2688-BC1C-4CC2-A12A-370D4A11011BQ41486017-C74C14DF-9AFC-4CE0-8462-CF015A6E78C2Q54190030-342E1DE6-5FE2-4526-BF2F-B3B533577CFBQ56341805-1B19A0C8-92E9-4767-8100-03A5E28342E0Q56986963-BB4C2B62-D71E-4BCA-A20E-950A2C361DD6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marzia Govoni
@ast
Marzia Govoni
@en
Marzia Govoni
@es
Marzia Govoni
@nl
type
label
Marzia Govoni
@ast
Marzia Govoni
@en
Marzia Govoni
@es
Marzia Govoni
@nl
prefLabel
Marzia Govoni
@ast
Marzia Govoni
@en
Marzia Govoni
@es
Marzia Govoni
@nl
P106
P31
P496
0000-0003-1673-0107